USD 0.09
(10.97%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 3.25 Million USD | -100.0% |
2023 | 4.28 Million USD | 60.79% |
2022 | 2.66 Million USD | -31.14% |
2021 | 3.87 Million USD | -54.98% |
2020 | 8.59 Million USD | 182.43% |
2019 | 3.04 Million USD | -7.06% |
2018 | 3.27 Million USD | -7.71% |
2017 | 3.54 Million USD | -7.44% |
2016 | 3.83 Million USD | -6.83% |
2015 | 4.11 Million USD | 227.93% |
2014 | 1.25 Million USD | -19.63% |
2013 | 1.56 Million USD | -18.5% |
2012 | 1.91 Million USD | -14.39% |
2011 | 2.23 Million USD | -14.06% |
2010 | 2.6 Million USD | -9.61% |
2009 | 2.88 Million USD | -5.4% |
2008 | 3.04 Million USD | -6.32% |
2007 | 3.25 Million USD | 60.7% |
2006 | 2.02 Million USD | 52.1% |
2005 | 1.33 Million USD | -14.38% |
2004 | 1.55 Million USD | -11.42% |
2003 | 1.75 Million USD | -10.06% |
2002 | 1.95 Million USD | 6.29% |
2001 | 1.83 Million USD | -11.52% |
2000 | 2.07 Million USD | -13.59% |
1999 | 2.4 Million USD | -14.29% |
1998 | 2.8 Million USD | 33.33% |
1997 | 2.1 Million USD | -16.0% |
1996 | 2.5 Million USD | 19.05% |
1995 | 2.1 Million USD | -4.55% |
1994 | 2.2 Million USD | 100.0% |
1993 | 1.1 Million USD | 1000.0% |
1992 | 100 Thousand USD | 0.0% |
1991 | - USD | 0.0% |
1990 | - USD | 0.0% |
1989 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q4 | 3.25 Million USD | -100.0% |
2024 Q1 | 3.95 Million USD | 0.0% |
2024 Q3 | 3.47 Million USD | -5.87% |
2024 Q2 | 3.69 Million USD | -6.63% |
2023 FY | 4.28 Million USD | 60.79% |
2023 Q1 | 2.45 Million USD | -7.82% |
2023 Q4 | 4.28 Million USD | -7.17% |
2023 Q3 | 4.61 Million USD | 10.02% |
2023 Q2 | 4.19 Million USD | 70.79% |
2022 Q1 | 3.54 Million USD | -8.32% |
2022 Q3 | 2.87 Million USD | -9.92% |
2022 Q2 | 3.19 Million USD | -10.07% |
2022 FY | 2.66 Million USD | -31.14% |
2022 Q4 | 2.66 Million USD | -7.29% |
2021 Q2 | 6.24 Million USD | -20.57% |
2021 FY | 3.87 Million USD | -54.98% |
2021 Q1 | 7.85 Million USD | -8.64% |
2021 Q3 | 4.62 Million USD | -25.85% |
2021 Q4 | 3.87 Million USD | -16.33% |
2020 Q2 | 5.2 Million USD | -6.27% |
2020 Q1 | 5.55 Million USD | 82.34% |
2020 Q3 | 4.84 Million USD | -6.9% |
2020 Q4 | 8.59 Million USD | 77.5% |
2020 FY | 8.59 Million USD | 182.43% |
2019 Q3 | 3.16 Million USD | 2.84% |
2019 Q4 | 3.04 Million USD | -3.69% |
2019 FY | 3.04 Million USD | -7.06% |
2019 Q1 | 3.17 Million USD | -3.05% |
2019 Q2 | 3.07 Million USD | -3.21% |
2018 Q4 | 3.27 Million USD | -0.14% |
2018 FY | 3.27 Million USD | -7.71% |
2018 Q1 | 3.46 Million USD | -2.52% |
2018 Q3 | 3.28 Million USD | -2.75% |
2018 Q2 | 3.37 Million USD | -2.51% |
2017 Q4 | 3.54 Million USD | -2.33% |
2017 FY | 3.54 Million USD | -7.44% |
2017 Q1 | 3.74 Million USD | -2.46% |
2017 Q2 | 3.65 Million USD | -2.21% |
2017 Q3 | 3.63 Million USD | -0.65% |
2016 Q4 | 3.83 Million USD | -2.09% |
2016 FY | 3.83 Million USD | -6.83% |
2016 Q3 | 3.91 Million USD | -1.14% |
2016 Q2 | 3.96 Million USD | -1.92% |
2016 Q1 | 4.03 Million USD | -1.86% |
2015 Q3 | 4.22 Million USD | -1.47% |
2015 Q1 | 4.38 Million USD | 249.62% |
2015 Q2 | 4.28 Million USD | -2.28% |
2015 FY | 4.11 Million USD | 227.93% |
2015 Q4 | 4.11 Million USD | -2.58% |
2014 Q1 | 1.47 Million USD | -5.27% |
2014 Q4 | 1.25 Million USD | -5.61% |
2014 Q2 | 1.4 Million USD | -5.13% |
2014 Q3 | 1.32 Million USD | -5.26% |
2014 FY | 1.25 Million USD | -19.63% |
2013 Q2 | 1.69 Million USD | -6.38% |
2013 Q4 | 1.56 Million USD | -4.91% |
2013 Q3 | 1.64 Million USD | -3.31% |
2013 FY | 1.56 Million USD | -18.5% |
2013 Q1 | 1.81 Million USD | -5.32% |
2012 Q1 | 2.16 Million USD | -3.29% |
2012 Q3 | 2.01 Million USD | -3.89% |
2012 FY | 1.91 Million USD | -14.39% |
2012 Q4 | 1.91 Million USD | -4.98% |
2012 Q2 | 2.09 Million USD | -3.07% |
2011 FY | 2.23 Million USD | -14.06% |
2011 Q4 | 2.23 Million USD | -3.91% |
2011 Q3 | 2.32 Million USD | -3.82% |
2011 Q2 | 2.42 Million USD | -3.62% |
2011 Q1 | 2.51 Million USD | -3.52% |
2010 Q1 | 2.79 Million USD | -2.99% |
2010 FY | 2.6 Million USD | -9.61% |
2010 Q4 | 2.6 Million USD | -4.02% |
2010 Q3 | 2.71 Million USD | 0.05% |
2010 Q2 | 2.71 Million USD | -2.97% |
2009 FY | 2.88 Million USD | -5.4% |
2009 Q1 | 3 Million USD | -1.23% |
2009 Q4 | 2.88 Million USD | 0.91% |
2009 Q2 | 2.92 Million USD | -2.73% |
2009 Q3 | 2.85 Million USD | -2.41% |
2008 Q2 | 3.17 Million USD | -2.01% |
2008 Q3 | 3.11 Million USD | -2.08% |
2008 FY | 3.04 Million USD | -6.32% |
2008 Q4 | 3.04 Million USD | -2.06% |
2008 Q1 | 3.24 Million USD | -0.31% |
2007 Q1 | 1.96 Million USD | -2.73% |
2007 FY | 3.25 Million USD | 60.7% |
2007 Q4 | 3.25 Million USD | 75.35% |
2007 Q3 | 1.85 Million USD | -2.98% |
2007 Q2 | 1.91 Million USD | -2.9% |
2006 FY | 2.02 Million USD | 52.1% |
2006 Q1 | 1.27 Million USD | -4.23% |
2006 Q2 | 2.15 Million USD | 68.78% |
2006 Q3 | 2.08 Million USD | -3.02% |
2006 Q4 | 2.02 Million USD | -2.97% |
2005 Q4 | 1.33 Million USD | -4.93% |
2005 FY | 1.33 Million USD | -14.38% |
2005 Q1 | 1.5 Million USD | -3.4% |
2005 Q2 | 1.44 Million USD | -3.43% |
2005 Q3 | 1.39 Million USD | -3.46% |
2004 Q3 | 1.6 Million USD | -3.11% |
2004 Q2 | 1.65 Million USD | -3.1% |
2004 Q1 | 1.7 Million USD | -2.77% |
2004 Q4 | 1.55 Million USD | -2.95% |
2004 FY | 1.55 Million USD | -11.42% |
2003 FY | 1.75 Million USD | -10.06% |
2003 Q1 | 1.89 Million USD | -2.78% |
2003 Q3 | 1.81 Million USD | -2.33% |
2003 Q2 | 1.85 Million USD | -1.93% |
2003 Q4 | 1.75 Million USD | -3.42% |
2002 Q2 | 1.75 Million USD | -1.31% |
2002 FY | 1.95 Million USD | 6.29% |
2002 Q4 | 1.95 Million USD | 14.54% |
2002 Q3 | 1.7 Million USD | -2.96% |
2002 Q1 | 1.77 Million USD | -3.1% |
2001 Q3 | 1.89 Million USD | -3.14% |
2001 FY | 1.83 Million USD | -11.52% |
2001 Q1 | 2.01 Million USD | -2.83% |
2001 Q2 | 1.95 Million USD | -2.98% |
2001 Q4 | 1.83 Million USD | -3.1% |
2000 FY | 2.07 Million USD | -13.59% |
2000 Q2 | 2.2 Million USD | -4.35% |
2000 Q3 | 2.12 Million USD | -3.33% |
2000 Q4 | 2.07 Million USD | -2.48% |
2000 Q1 | 2.3 Million USD | -4.17% |
1999 Q1 | 2.8 Million USD | 0.0% |
1999 Q3 | 2.3 Million USD | 0.0% |
1999 Q4 | 2.4 Million USD | 4.35% |
1999 Q2 | 2.3 Million USD | -17.86% |
1999 FY | 2.4 Million USD | -14.29% |
1998 Q2 | 2 Million USD | 0.0% |
1998 Q3 | 2.2 Million USD | 10.0% |
1998 Q4 | 2.8 Million USD | 27.27% |
1998 FY | 2.8 Million USD | 33.33% |
1998 Q1 | 2 Million USD | -4.76% |
1997 Q2 | 2.4 Million USD | -4.0% |
1997 Q4 | 2.1 Million USD | 0.0% |
1997 FY | 2.1 Million USD | -16.0% |
1997 Q1 | 2.5 Million USD | 0.0% |
1997 Q3 | 2.1 Million USD | -12.5% |
1996 Q3 | 2 Million USD | 0.0% |
1996 FY | 2.5 Million USD | 19.05% |
1996 Q1 | 2.1 Million USD | 0.0% |
1996 Q2 | 2 Million USD | -4.76% |
1996 Q4 | 2.5 Million USD | 25.0% |
1995 Q1 | 2.2 Million USD | 0.0% |
1995 FY | 2.1 Million USD | -4.55% |
1995 Q4 | 2.1 Million USD | 0.0% |
1995 Q3 | 2.1 Million USD | -4.55% |
1995 Q2 | 2.2 Million USD | 0.0% |
1994 Q3 | 2.4 Million USD | 4.35% |
1994 Q1 | 1.9 Million USD | 72.73% |
1994 Q2 | 2.3 Million USD | 21.05% |
1994 Q4 | 2.2 Million USD | -8.33% |
1994 FY | 2.2 Million USD | 100.0% |
1993 FY | 1.1 Million USD | 1000.0% |
1993 Q3 | 700 Thousand USD | 133.33% |
1993 Q1 | 100 Thousand USD | 0.0% |
1993 Q2 | 300 Thousand USD | 200.0% |
1993 Q4 | 1.1 Million USD | 57.14% |
1992 Q4 | 100 Thousand USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 FY | 100 Thousand USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1992 Q3 | 100 Thousand USD | 0.0% |
1991 FY | - USD | 0.0% |
1991 Q2 | - USD | 0.0% |
1991 Q1 | - USD | 0.0% |
1991 Q3 | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1990 FY | - USD | 0.0% |
1990 Q4 | - USD | 0.0% |
1989 Q4 | - USD | 0.0% |
1989 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acutus Medical, Inc. | 32.65 Million USD | 90.021% |
Biotricity, Inc. | 10.85 Million USD | 69.984% |
Cell MedX Corp. | - USD | -Infinity% |
Nemaura Medical Inc. | 3.08 Million USD | -5.533% |
PetVivo Holdings, Inc. | 1.01 Million USD | -220.423% |
RetinalGenix Technologies Inc. | - USD | -Infinity% |
Sonendo, Inc. | 14.03 Million USD | 76.783% |
Telesis Bio, Inc. | 5.26 Million USD | 38.158% |
Talis Biomedical Corporation | 16.78 Million USD | 80.588% |
Viveve Medical, Inc. | 5.12 Million USD | 36.408% |